Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara bo... by Allen, T, Vogel, T, Fuller, D, Mothé, B, Steffen, S, Boyson, J, Shipley, T, Fuller, J, Hanke, T, Sette, A, Altman, J, Moss, B, Mcmichael, A, Watkins, D

DNA vaccines expressing conserved elements provide potent and broad immune responses by Pavlakis GN, Kulkarni V, Valentin A, Rosati M, Sardesai NY, Mothe B, Brander C, LeGall S, Weiner DB, Rolland M, Mullins JI, Felber BK

In vivo effects of romidepsin on T-cell activation, apoptosis and function in the BCN02 HIV-1 kick&kill clinical trial by Rosás-Umbert, M, Ruiz-Riol, M, Fernández, MA, Marszalek, M, Coll, P, Manzardo, C, Cedeño, S, Miró, JM, Clotet, B, Hanke, T, Moltó, J, Mothe, B, Brander, C, BCN02 study group

Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses by Yang, H, Llano, A, Cedeño, S, von Delft, A, Corcuera, A, Gillespie, GM, Knox, A, Leneghan, DB, Frater, J, Stöhr, W, Fidler, S, Mothe, B, Mak, J, Brander, C, Ternette, N, Dorrell, L

S011-06 OA. HIV specific T cell responses and response patterns associated with viral control independent of classical non-progessor HLA class I alleles by Goulder P, Heckerman D, Lucchetti A, Hildebrand W, Szinger JJ, Suarez J, Farfan M, Daniels M, Ibarrondo J, Llano A, Mothe B, Zuniga R, Walker BD, Sanchez J, Korber BT, Brander C

HIV specific T cell responses and response patterns associated with viral control independent of classical non-progessor HLA class I alleles by Zuniga, R, Mothe, B, Llano, A, Ibarrondo, J, Daniels, M, Farfan, M, Suarez, J, Szinger, J, Hildebrand, W, Lucchetti, A, Heckerman, D, Goulder, P, Walker, B, Sanchez, J, Korber, B, Brander, C

S011-06 OA. HIV specific T cell responses and response patterns associated with viral control independent of classical non-progessor HLA class I alleles by Zuniga, R, Mothe, B, Llano, A, Ibarrondo, J, Daniels, M, Farfan, M, Suarez, J, Szinger, J, Hildebrand, W, Lucchetti, A, Heckerman, D, Goulder, P, Walker, B, Sanchez, J, Korber, B, Brander, C

Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers by Rosás-Umbert, M, Llano, A, Bellido, R, Olvera, A, Ruiz-Riol, M, Rocafort, M, Fernández, M, Cobarsi, P, Crespo, M, Dorrell, L, Del Romero, J, Alcami, J, Paredes, R, Brander, C, Mothe, B

Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells. by Ternette, N, Yang, H, Partridge, T, Llano, A, Cedeño, S, Fischer, R, Charles, P, Dudek, N, Mothe, B, Crespo, M, Fischer, W, Korber, B, Nielsen, M, Borrow, P, Purcell, A, Brander, C, Dorrell, L, Kessler, B, Hanke, T

HLA alleles, COVID-19 vaccine antibody response and real-world breakthrough outcomes by Xie, J, Mothe, B, Herraiz, MA, Li, C, Xu, Y, Jödicke, AM, Gao, Y, Feng, S, Wei, J, Chen, Z, Hong, S, Wu, Y, Su, B, Zheng, X, Cohet, C, Ali, R, Wareham, N, Prieto-Alhambra, D

Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses by Hancock, G, Yang, H, Yorke, E, Wainwright, E, Bourne, V, Frisbee, A, Payne, T, Berrong, M, Ferrari, G, Chopera, D, Hanke, T, Mothe, B, Brander, C, McElrath, M, McMichael, A, Goonetilleke, N, Tomaras, G, Frahm, N, Dorrell, L

Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes by Xie, J, Mothe, B, Alcalde Herraiz, M, Li, C, Xu, Y, Jödicke, AM, Gao, Y, Wang, Y, Feng, S, Wei, J, Chen, Z, Hong, S, Wu, Y, Su, B, Zheng, X, Cohet, C, Ali, R, Wareham, N, Prieto Alhambra, D

The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-... by Altfeld, M, Allen, T, Kalife, E, Frahm, N, Addo, M, Mothe, B, Rathod, A, Reyor, L, Harlow, J, Yu, X, Perkins, B, Robinson, L, Sidney, J, Alter, G, Lichterfeld, M, Sette, A, Rosenberg, E, Goulder, P, Brander, C, Walker, B

Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. by Allen, T, Altfeld, M, Yu, X, O'Sullivan, K, Lichterfeld, M, Le Gall, S, John, M, Mothe, B, Lee, P, Kalife, E, Cohen, D, Freedberg, K, Strick, D, Johnston, M, Sette, A, Rosenberg, E, Mallal, SA, Goulder, P, Brander, C, Walker, B

Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection. by Allen, T, Jing, P, Calore, B, Horton, H, O'Connor, D, Hanke, T, Piekarczyk, M, Ruddersdorf, R, Mothé, B, Emerson, C, Wilson, N, Lifson, J, Belyakov, I, Berzofsky, J, Wang, C, Allison, D, Montefiori, D, Desrosiers, R, Wolinsky, S, Kunstman, K, Altman, J, Sette, A, Mcmichael, A, Watkins, D

Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints. by Payne, R, Branch, S, Kløverpris, H, Matthews, P, Koofhethile, C, Strong, T, Adland, E, Leitman, E, Frater, J, Ndung'u, T, Hunter, E, Haubrich, R, Mothe, B, Edwards, A, Riddell, L, Chen, F, Harrigan, P, Brumme, Z, Mallal, S, John, M, Jooste, J, Shapiro, R, Deeks, S, Walker, B, Brander, C

Definition of the viral targets of protective HIV-1-specific T cell responses. by Mothe, B, Llano, A, Ibarrondo, J, Daniels, M, Miranda, C, Zamarreño, J, Bach, V, Zuniga, R, Pérez-Álvarez, S, Berger, C, Puertas, M, Martinez-Picado, J, Rolland, M, Farfan, M, Szinger, J, Hildebrand, W, Yang, O, Sanchez-Merino, V, Brumme, C, Brumme, Z, Heckerman, D, Allen, T, Mullins, J, Gómez, G, Goulder, P

Therapeutic vaccination refocuses t-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study) by Mothe, B, Manzardo, C, Sanchez-Bernabeu, A, Coll, P, Morón-López, S, Puertas, MC, Rosas-Umbert, M, Cobarsi, P, Escrig, R, Perez-Alvarez, N, Ruiz, I, Rovira, C, Meulbroek, M, Crook, A, Borthwick, N, Wee, EG, Yang, H, Miró, JM, Dorrell, L, Clotet, B, Martinez-Picado, J, Brander, C, Hanke, T, BCN 01 study group

HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: Safety, immunogenicity and effect on the viral reservoir (Study BCN02) by Mothe, B, Rosás-Umbert, M, Coll, P, Manzardo, C, Puertas, MC, Morón-López, S, Llano, A, Miranda, C, Cedeño, S, López, M, Alarcón-Soto, Y, Gómez Melis, G, Langohr, K, Barriocanal, AM, Toro, J, Ruiz, I, Rovira, C, Carrillo, A, Meulbroek, M, Crook, A, Wee, EG, Miró, JM, Clotet, B, Valle, M, Martinez-Picado, J, Hanke, T, Brander, C, Moltó, J, BCN02 Study Investigators

Differential immunodominance hierarchy of CD8+ T cell responses in HLA-B*27:05 and B*27:02-mediated control of HIV-1 infection. by Adland, E, Hill, M, Lavandier, N, Csala, A, Edwards, A, Chen, F, Radkowski, M, Kowalska, J, Paraskevis, D, Hatzakis, A, Valenzuela-Ponce, H, Pfafferott, K, Williams, I, Pellegrino, P, Borrow, P, Mori, M, Rockstroh, J, Prado, J, Mothe, B, Dalmau, J, Martinez-Picado, J, Tudor-Williams, G, Frater, A, Stryhn, A, Buus, S, Reyes Teran, G, Mallal, S, John, M, Buchbinder, S, Kirk, G, Martin, J, Michael, N, Fellay, J, Deeks, S, Walker, B, Avila-Rios, S, Cole, D, Brander, C, Carrington, M, Goulder, P